ARTV
ARTV
NASDAQ · Biotechnology

Artiva Biotherapeutics Inc

$7.05
+0.06 (+0.86%)
As of Sep 28, 10:23 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +15.5% upside
Low Target $7.28
Average Target $8.14
High Target $10.62
Current Price $7.05
Current
$7.05
Target
$8.14
$7.28 $8.14 avg $10.62
Scenario Analysis
Bear Case
$7.28
3.3%
Low target
Base Case
$8.14
+15.5%
Avg target
Bull Case
$10.62
+50.6%
High target
Risk/Reward
15.5x
Highly favorable
Price in Context
52-Week High
$14.53
-51.5% from high
52-Week Low
$2.52
+179.8% from low
Target vs 52W High
$8.14
-44.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%